WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Vladimir Jurisic
1,070 Points

Contributions by role

Editor 1,070

Contributions by subject area

Evidence Based Medicine
Hematology
Immunology
Clinical Trials
Neurology
Rheumatology
Oncology
Medical Genetics
Pathology
Bioinformatics
Biochemistry
Emergency and Critical Care
Geriatrics
Gastroenterology and Hepatology
Surgery and Surgical Specialties
Histology
Cardiology
Radiology and Medical Imaging
Genetics
Urology
Healthcare Services
Dentistry
Drugs and Devices
Nutrition

Vladimir Jurisic


Summary

Vladimir Jurisic, MD, PhD, is a professor of Physiopathology within the Faculty of Medical Sciences at the University of Kragujevac, Serbia.

His primary areas of expertise include, Immunology, Hematology, Oncology, Inflammation, NK cells and Cytokines.

Hematology Immunology Oncology

Past or current institution affiliations

University of Kragujevac

Work details

Faculty of Medical Sciencies

University of Kragujevac
Faculty of Medical Sciencies

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 8

Academic Editor on

December 6, 2024
Nonlinear relationship between circulating natural killer cell count and 1-year relapse rates in myasthenia gravis: a retrospective cohort study
Yifan Zhang, Zhiguo Wen, Meiqiu Chen, Cong Xia, Fang Cai, Lan Chu
https://doi.org/10.7717/peerj.18562 PubMed 39655331
November 29, 2024
Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis
Zhilei Zhang, Fang Liu, Yongbo Yu, Fei Xie, Tao Zhu
https://doi.org/10.7717/peerj.18530 PubMed 39624133
November 15, 2024
Evaluating the efficacy of curcumin in the management of oral potentially malignant disorders: a systematic review and meta-analysis
Wenjin Shi, Qiuhao Wang, Sixin Jiang, Yuqi Wu, Chunyu Li, Yulang Xie, Qianming Chen, Xiaobo Luo
https://doi.org/10.7717/peerj.18492 PubMed 39559334
July 18, 2024
The prognostic role of lymphocyte-to-monocyte ratio in patients with resectable pancreatic cancer: a systematic review and meta-analysis
Haipeng Li, Shang Peng, Ran An, Nana Du, Huan Wu, Xiangcheng Zhen, Yuanzhi Gao, Zhenghong Li, Jingting Min
https://doi.org/10.7717/peerj.17585 PubMed 39035167
July 9, 2024
Cancer histology in metastatic lymph node predicts prognosis in patients with node-positive stage IV colorectal cancer
Shozo Yokoyama, Takashi Watanabe, Shuichi Matsumura, Masato Tamiya, Shotaro Nagano, Yuya Hori
https://doi.org/10.7717/peerj.17702 PubMed 39006028
June 3, 2024
Peripheral blood immune cell parameters in patients with high-grade squamous intraepithelial lesion (HSIL) and cervical cancer and their clinical value: a retrospective study
Ling Wang, Yuyan Dong
https://doi.org/10.7717/peerj.17499 PubMed 38846752
May 1, 2024
Significance of NKX2-1 as a biomarker for clinical prognosis, immune infiltration, and drug therapy in lung squamous cell carcinoma
Huiyue Lin, Juyong Wang, Qing Shi, Minmin Wu
https://doi.org/10.7717/peerj.17338 PubMed 38708353
April 22, 2024
Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis
En-min Zhou, Heping Shen, Di Wang, Weiqun Xu
https://doi.org/10.7717/peerj.17152 PubMed 38666084